Skip to content
10-Q

Quarterly Report

Shuttle Pharmaceuticals, Inc.

0001615774-17-003365

← back to feed
Filed
Jun 26, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Jun 26, 2017 45M sh
Cash And Equivalents Q1 2017 · Mar 31, 2017 $97.51K
Cash And Equivalents Q1 2017 · Dec 31, 2016 $92.8K
Cash And Equivalents Q1 2017 · Mar 31, 2016 $174.81K
Cash And Equivalents Q1 2017 · Dec 31, 2015 $128.84K
Stockholders Equity Q1 2017 · Mar 31, 2017 −$175.3K
Stockholders Equity Q1 2017 · Dec 31, 2016 −$70.85K
Current Liabilities Q1 2017 · Mar 31, 2017 $252.32K
Current Liabilities Q1 2017 · Dec 31, 2016 $105.28K
Total Liabilities Q1 2017 · Mar 31, 2017 $372.57K
Total Liabilities Q1 2017 · Dec 31, 2016 $225.53K
Current Assets Q1 2017 · Mar 31, 2017 $163.35K
Current Assets Q1 2017 · Dec 31, 2016 $115.93K
Total Assets Q1 2017 · Mar 31, 2017 $197.27K
Total Assets Q1 2017 · Dec 31, 2016 $154.68K
Sga Expense Q1 2017 · Mar 31, 2017 $25.47K
Sga Expense Q1 2017 · Mar 31, 2016 $10.51K
Rd Expense Q1 2017 · Mar 31, 2017 $217.05K
Rd Expense Q1 2017 · Mar 31, 2016 $146.9K
Net Income Q1 2017 · Mar 31, 2017 −$104.55K
Net Income Q1 2017 · Mar 31, 2016 −$24.41K
Operating Income Q1 2017 · Mar 31, 2017 −$102.01K
Operating Income Q1 2017 · Mar 31, 2016 −$24.65K